News

Filter

Neuroscience

March 17, 2021
Brain rewires itself after injury ‘on the edge of what’s compatible with life’
Stroke suffered as newborn went undetected for 13 years.
News Release
March 15, 2021
International Alzheimer’s clinical trial to test tau drugs
Antibody is first of 3 tau drugs to be evaluated.
News Release
March 11, 2021
Combating COVID-19: Labs pivot to fight a common enemy
Labs retooled to investigate how the virus causes disease and to develop drugs, vaccines and diagnostics.
Outlook Magazine
March 7, 2021
Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant
Source: CBS News/60 Minutes
March 2, 2021
Opioid overdose reduced in patients taking buprenorphine
Study indicates the drug is effective in opioid users who also take benzodiazepines for anxiety, other conditions .
News Release
February 26, 2021
Electrical signaling in cells focus of $8.8 million grant
Scientists to explore cells' ion channels in seeking new treatments for arrythmias, epilepsy, other disorders.
News Release
February 17, 2021
Protein linked to Alzheimer’s, strokes cleared from brain blood vessels
In mice, antibody removes amyloid, improves vessel function without raising risk of brain bleeds.
News Release
January 27, 2021
How does the immune system keep tabs on the brain?
Study finds site of immune surveillance of the brain, points to new ways to target brain inflammation.
News Release
January 14, 2021
Acute itching in eczema patients linked to environmental allergens
Newly identified pathway explains why antihistamine drugs often don’t work to control severe itch.
News Release
January 12, 2021
Doctors test popular anti-depressant to see if it fights off COVID-19
Source: CNN
December 28, 2020
Common brain malformation traced to its genetic roots
Discovery could aid early screening, shed light on how Chiari malformation arises.
News Release
December 16, 2020
Protein involved in removing Alzheimer’s buildup linked to circadian rhythm
Brain protein helps explain link between circadian rhythm, Alzheimer’s disease.
News Release
December 8, 2020
Bateman, Diamond, Hultgren named to National Academy of Inventors
School of Medicine scientists honored for innovation.
News Release
December 7, 2020
Novel form of Alzheimer’s protein found in spinal fluid indicates stage of the disease
Discovery could lead to better diagnostics, speed efforts to find treatment.
News Release
November 24, 2020
Severe scoliosis in African Americans focus of $3.2 million grant
Study examines genetic risk factors associated with spinal curvature.
News Release
November 19, 2020
Young people with disabilities focus of COVID-19 testing grant
$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County.
News Release
November 12, 2020
Fluvoxamine may prevent serious illness in COVID-19 patients
Antidepressant drug repurposed for patients with coronavirus infection.
News Release
November 4, 2020
Improving emergency care for people with dementia is focus of new grant
Washington University among 4 institutions to share total of $7.5 million from NIH to study, improve care in emergency departments.
News Release
November 2, 2020
New insight into how brain neurons influence choices
Effort could aid study of addiction, eating disorders, other neuropsychiatric conditions that involve faulty decision-making.
News Release
October 22, 2020
Alzheimer’s in adults with Down syndrome focus of multicenter NIH grant
As part of grant totaling more than $100 million, Washington University to lead research sections on Alzheimer’s development, genetics.
News Release
October 21, 2020
Uncovering genetic roots of marijuana use disorder
As more states enact laws legalizing pot, addiction problems may increase.
News Release
October 15, 2020
Neuroscientist Ponce named a 2020 Packard fellow
One of only 20 nationwide to achieve this honor.
News Release
October 12, 2020
Racial differences in Alzheimer’s research focus of $15 million grant
Study investigates whether biological markers of Alzheimer’s in white patients also apply to African Americans.
News Release
October 6, 2020
Brain inflammation in Parkinson’s disease focus of $3.2 million grant
Study probes inflammation’s role in spreading brain damage; may have implications for MS, Alzheimer’s, other neurodegenerative diseases.
News Release
October 2, 2020
Basis of developmental disabilities focus of $11.3 million in grants
Research to examine genetic, environmental factors linked to such disabilities and how to improve lives of those affected.
News Release
September 14, 2020
Older people with early, asymptomatic Alzheimer’s at risk of falls
Even without cognitive problems, those with Alzheimer’s-related brain damage at increased risk of falls.
News Release
September 3, 2020
Global trial to test whether MMR vaccine protects front-line health-care workers against COVID-19
Vaccine may strengthen immune response to viral infections; trial to enroll up to 30,000 health-care workers .
News Release
August 31, 2020
College students access eating disorders therapy via phone app
Multi-university study shows app can help students reduce symptoms, ease depression.
News Release
August 28, 2020
COVID-19 disproportionately affects developmentally disabled
In great need of in-person supports, developmentally disabled are overlooked in pandemic-related decisions, experts say.
News Release
August 23, 2020
African American children with autism experience long delays in diagnosis
Such delays lead to serious disparities in access to developmental therapy.
News Release
August 19, 2020
New center to explore brain, immune system connections
Discoveries will aid efforts to develop immune therapies for neurological diseases.
News Release
August 4, 2020
Boosting immune system a potential treatment strategy for COVID-19
Researchers find weakened, rather than hyperactive, immunity in response to virus.
News Release
July 28, 2020
Alzheimer’s protein in blood indicates early brain changes
Promising target for blood-based diagnostic test.
News Release
July 8, 2020
Experimental drug shows early promise against inherited form of ALS, trial indicates
Phase 1/phase 2 trial shows evidence for safety, biological activity of tofersen; phase 3 trial underway.
News Release
July 6, 2020
Study to examine social media’s effects on stress during COVID-19 pandemic
National Science Foundation grant funds analysis, Twitter-based interventions.
News Release
June 22, 2020
Schizophrenia, other psychotic disorders focus of new clinic for teens, young adults
Clinic services provided free of charge.
News Release